GENEDX HOLDINGS CORP (WGS)
US81663L2007 - Common Stock
Taking everything into account, WGS scores 3 out of 10 in our fundamental rating. WGS was compared to 117 industry peers in the Health Care Providers & Services industry. While WGS seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, WGS is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
WGS had negative earnings in the past year.
WGS had a negative operating cash flow in the past year.
In the past 5 years WGS always reported negative net income.
In the past 5 years WGS always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of WGS (-41.98%) is worse than 86.21% of its industry peers.
The Return On Equity of WGS (-77.09%) is worse than 73.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.98% | ||
| ROE | -77.09% | ||
| ROIC | N/A |
ROA(3y)-66.03%
ROA(5y)-62.01%
ROE(3y)-118.9%
ROE(5y)-1173.25%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 44.44%, WGS is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of WGS has grown nicely.
The Profit Margin and Operating Margin are not available for WGS so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.44% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y7.53%
2. Health
2.1 Basic Checks
WGS does not have a ROIC to compare to the WACC, probably because it is not profitable.
WGS has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, WGS has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -3.94, we must say that WGS is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of WGS (-3.94) is worse than 84.48% of its industry peers.
WGS has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
WGS has a Debt to Equity ratio of 0.31. This is in the better half of the industry: WGS outperforms 67.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.94 |
ROIC/WACCN/A
WACC8.66%
2.3 Liquidity
A Current Ratio of 3.10 indicates that WGS has no problem at all paying its short term obligations.
The Current ratio of WGS (3.10) is better than 86.21% of its industry peers.
WGS has a Quick Ratio of 2.95. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS's Quick ratio of 2.95 is amongst the best of the industry. WGS outperforms 87.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.1 | ||
| Quick Ratio | 2.95 |
3. Growth
3.1 Past
WGS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.23%, which is quite impressive.
The Revenue for WGS has decreased by -13.69% in the past year. This is quite bad
Measured over the past years, WGS shows a quite strong growth in Revenue. The Revenue has been growing by 8.73% on average per year.
EPS 1Y (TTM)83.23%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q91.64%
Revenue 1Y (TTM)-13.69%
Revenue growth 3Y4.15%
Revenue growth 5Y8.73%
Revenue growth Q2Q-6.41%
3.2 Future
WGS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.82% yearly.
The Revenue is expected to grow by 18.78% on average over the next years. This is quite good.
EPS Next Y62.66%
EPS Next 2Y35.62%
EPS Next 3Y25.82%
EPS Next 5YN/A
Revenue Next Year16.14%
Revenue Next 2Y16.77%
Revenue Next 3Y18.78%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
WGS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WGS. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
WGS's earnings are expected to grow with 25.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.62%
EPS Next 3Y25.82%
5. Dividend
5.1 Amount
No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
GENEDX HOLDINGS CORP
NASDAQ:WGS (4/26/2024, 7:24:14 PM)
11.08
-0.09 (-0.81%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap288.63M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -41.98% | ||
| ROE | -77.09% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 44.44% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.31 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.1 | ||
| Quick Ratio | 2.95 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.23%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y62.66%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-13.69%
Revenue growth 3Y4.15%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y